
Prevymis
My Prescription
Payment
Select pharmacy




$7,773.80
Print or send this coupon to your phone
About Prevymis
Drug Details
Letermovir, marketed under the brand name Prevymis, is an antiviral medication specifically designed to prevent cytomegalovirus (CMV) infections. It is primarily used in adult patients who have undergone a stem cell or kidney transplant and are at high risk of CMV infection. The medication operates by inhibiting a specific enzyme necessary for the virus to replicate, thereby halting its growth. Prevymis is taken once daily and is only available as a brand-name drug. Common side effects include nausea, diarrhea, and vomiting. It is important to consult with a healthcare professional before starting this medication as it may interact with other drugs.
Price history for Prevymis
28 Tablets, 480MG
Average retail price for Prevymis
Average SaveHealth price for Prevymis
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Prevymis dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 240MG | 1 Tablet | $298.25 | $298.25 |
| 240MG | 14 Tablets | $4,012.97 | $286.64 |
| 240MG | 28 Tablets | $8,002.64 | $285.81 |
| 480MG | 28 Tablets | $8,002.64 | $285.81 |
| 480MG | 1 Tablet | $298.25 | $298.25 |
| 480MG | 14 Tablets | $4,012.97 | $286.64 |
Prevymis FAQs
Prevymis is used to prevent cytomegalovirus (CMV) infection and disease in adult patients who have received an allogeneic hematopoietic stem cell transplant. It is particularly used in patients who are at high risk for CMV reactivation.
The cost of Prevymis can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.
Yes, Prevymis (letermovir) is FDA approved. It is used to prevent cytomegalovirus (CMV) infection in adult patients who have received an allogeneic hematopoietic stem cell transplant.
Medicare coverage for Prevymis can vary depending on the specific Medicare plan. Generally, Medicare Part D or Medicare Advantage plans with prescription drug coverage may cover Prevymis. It is important for individuals to check with their specific plan provider to confirm coverage details, including any potential co-pays or prior authorization requirements.
Prevymis (letermovir) may cause several side effects. Common side effects include nausea, diarrhea, vomiting, headache, cough, fatigue, and swelling in the arms or legs. Less common but more serious side effects can include abnormal liver function tests and allergic reactions. It is important for individuals to report any unusual or severe symptoms to their healthcare provider.